Title of article
Effects of citalopram on heart rate variability in women with generalized anxiety disorder
Author/Authors
Ranjbar، Fatemeh نويسنده Associate Professor, Clinical Psychiatry Research Center, Tabriz University of Medical Sciences, Tabriz, Iran , , Akbarzadeh، Fariborz نويسنده , , Zakeri، Faramarz نويسنده Resident, Clinical Psychiatry Research Center, Tabriz University of Medical Sciences, Tabriz, Iran , , Farahbakhsh، Mostafa نويسنده Department of Psychology, Tabriz University of Medical Sciences, Tabriz, Iran Farahbakhsh, Mostafa , Nazari، Mohammad Ali نويسنده Assistant Professor, Department of Psychology, School of Psychology, University of Tabriz, Tabriz, Iran ,
Issue Information
دوماهنامه با شماره پیاپی 47 سال 2015
Pages
8
From page
196
To page
203
Abstract
BACKGROUND: Heart rate variability (HRV) is defined as variations in R-R interval with time.
Dysautonomia is common in patients with psychiatric disorders such as depression and anxiety.
Using HRV analysis, recent studies showed that in anxiety disorders, the vagal cardiac function
decreases, and sympathetic function increases. This study aimed at investigating citalopram
effects on HRV.
METHODS: This before and after study was conducted in 25 generalized anxiety disorder (GAD)
patients. GAD was diagnosed based on clinical interview according to diagnostic and statistical
manual of mental disorders IV-Text revised (DSM-IV-TR) criteria using Structured Clinical
Interview for DSM Disorders-I questionnaire. A cardiologist studied 24 h ambulatory
monitoring of the electrocardiogram (Holter) on all patients before the treatment. A volume of
20 mg of citalopram was administered to the subjects on a daily basis. Then, they were studied
by Holter monitoring again after 1-month of administration of citalopram.
RESULTS: The average age of participants was 35.32 ± 8.7. The average Holter monitoring time
was 23.29 ± 1.14 h before treatment and 23.81 ± 0.68 after it. The 3 h low frequency/high
frequency ratio was significantly different between 3 h segments of time before treatment
(P < 0.001). This difference was even higher after treatment (P = 0.001). Data showed an
increase in parasympathetic tone during sleep both before and after treatment.
CONCLUSION: These patients showed some impairments of HRV indices that did not improve
by citalopram in future, the clinical importance of such disturbances should be evaluated in
details with prolonged follow-up and greater sample size.
Journal title
Arya Atherosclerosis
Serial Year
2015
Journal title
Arya Atherosclerosis
Record number
2311321
Link To Document